SCM
GLSI icon

Sterling Capital Management’s Greenwich LifeSciences GLSI Stock Holding History

Sterling Capital Management’s Portfolio GLSI Stock Details GLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$961 Hold
40
– – ﹤0.01% 3102
2025
Q4 		$840 Buy
40
+25
+167% +$263 ﹤0.01% 3152
2025
Q3 		$149 Buy
15
+1
+7% +$11 ﹤0.01% 3228
2025
Q2 		$127 Buy
14
+8
+133% +$76 ﹤0.01% 3247
2025
Q1 		$57 Hold
6
– – ﹤0.01% 3173
2024
Q4 		$67 Hold
6
– – ﹤0.01% 3197
2024
Q3 		$86 Buy
+6
New +$89 ﹤0.01% 3204

Other funds holding GLSI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Sterling Capital Management's GLSI Position: Q1 2026 in Review

Sterling Capital Management held its Greenwich LifeSciences (GLSI) position steady in Q1 2026 at 40 shares worth $961. The position accounts for ﹤0.01% of the portfolio, ranked #3102.

Sterling Capital Management first reported a position in GLSI in Q3 2024 and has held it in 7 quarters since. 64 funds tracked by Wall St. Rank hold GLSI as of Q1 2026.

  • Sterling Capital Management held 40 shares of Greenwich LifeSciences worth $961 as of Q1 2026.
  • Sterling Capital Management left its Greenwich LifeSciences share count unchanged in Q1 2026.
  • Greenwich LifeSciences made up ﹤0.01% of Sterling Capital Management's portfolio in Q1 2026, its #3102 holding.
  • Sterling Capital Management first reported a position in Greenwich LifeSciences in Q3 2024 and has held it in 7 quarters since.
  • 64 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q1 2026.

Based on Sterling Capital Management's 13F filing for Q1 2026, filed 22 Apr 2026.